Actinium Pharmaceuticals Inc (NY: ATNM )
6.250 -0.050 (-0.79%) Streaming Delayed Price Updated: 11:40 AM EDT, Sep 25, 2023 Add to My Watchlist
All News about Actinium Pharmaceuticals Inc
Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia
February 22, 2023
– Iomab-B met the primary endpoint of durable Complete Remission (dCR) of 6-months following initial complete remission after BMT with high statistical significance (p-value of <0.0001), 22% of...